Keywords: Poroma; porocarcinoma; UV signature; HRAS; TP53; PIK3CA;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-
Keywords: mPFC; medial prefrontal cortex; UHPLC; ultrahigh performance liquid chromatography; CHAPS; 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate; LC-MS; liquid chromatography-mass spectrometry; LC-MS/MS; liquid chromatography-tandem mass spectrometry
Keywords: Spitz nevus; Atypical Spitz tumor; Spitzoid melanoma; HRAS; BAP1; Comparative genomic hybridization; Fluorescence in situ hybridization; Telomerase promoter;
Keywords: 3-AP; 3-aminopyridine-2-carboxaldehyde thiosemicarbazone; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and Rad3-related protein; AMP/ADP/ATP; adenosine mono-, di-, and tri-phosphate; BLM; Bloom syndrome RecQ helicase-like; BRAF; V-raf mu
Keywords: Anti-cancer therapies; Cancer attractors; Cancer stem cells; Hypoxia; Inflammation; Interactome; Metabolic modeling; Networks; Senescence; Signaling; AKT; RAC-alpha serine/threonine protein kinase; BMI1; polycomb ring finger oncogene; C/EBP; CCAAT/enhance
Keywords: CS; Costello syndrome; NS; Noonan syndrome; CFCS; cardiofaciocutaneous syndrome; NF1; neurofibromatosis type 1; DXA; dual-energy X-ray absorptiometry; BMD; bone mineral density; S-BMD; subtotal bone mineral density; WBLH; whole body less head; L-BMD; lumb
Keywords: conventional melanoma; melanoma; metastasis; prognosis; sentinel lymph node; sentinel lymph node biopsy; Spitzoid malignant melanoma; survival; BRAF; v-raf murine sarcoma viral oncogene homolog B; CMM; conventional malignant melanoma; HRAS; Harvey rat sar
Phosphorylation of synaptic GTPase-activating protein (synGAP) by polo-like kinase (Plk2) alters the ratio of its GAP activity toward HRas, Rap1 and Rap2 GTPases
Keywords: Synaptic plasticity; Synaptic scaling; Postsynaptic density; Synaptic GTPase activating protein (synGAP); Cyclin-dependent kinase 5 (CDK5); Polo-like kinase 2 (Plk2); synGAP; synaptic GTPase activating protein; r-synGAP; soluble recombinant synGAP fragmen
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Keywords: BATTLE; Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination; BET; bromodomains and extra-terminal domain; CDK; cyclin-dependent kinase; Chk1; checkpoint kinase 1; CI; confidence interval; CUSTOM; Molecular Profiling and Targete
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Keywords: Akt; oncogene in the transforming retrovirus, AKT8; AP-1; activator protein 1; ARAF; v-raf murine sarcoma 3611 viral oncogene homologue; ASK1; apoptosis signal-regulating kinase 1; BCL2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma extra large; BRAF; v-raf
Impact of obesity and overweight on DNA stability: Few facts and many hypotheses
Keywords: AGEs; advanced glycation end products; AP-1; activating protein -1; APE1; apurinic/apyrimidinic endonuclease 1; BER; base excision repair; BMI; body mass index; CAF; cafeteria diet; CAT; Catalase; CBMN-Cyt; cytokinesis block micronucleus cytome assay; CEL
Oncogenic mutations of PIK3CA and HRAS in carcinoma of cervix in South Indian women
Keywords: Oncogenic mutations; Cervical cancer; Peripheral blood; PCR-CTPP method; PIK3CA; Phosphatidylinositol-4,5-Bisphosphate; 3-Kinase Catalytic Subunit Alpha; HRAS; Harvey rat sarcoma viral oncogene homolog; EGF; Epidermal Growth Factor; PDGF; Platelet Derived
Development of a light-up fluorescent probe for HRAS G-quadruplex DNA
Keywords: G-quadruplex DNA; HRAS; Fluorescent probe; Living cell imaging;
The role of RAS mutations in MLL-rearranged leukaemia: A path to intervention?
Keywords: ALL; acute lymphoblastic leukaemia; iALL; infant ALL; MLL; myeloid/lymphoid leukaemia or mixed lineage leukaemia, also known as KMT2A; RAS; rat sarcoma; BCP-ALL; B-cell precursor ALL; EFS; event-free survival; OS; overall survival; WBC; white blood cell c
8-Oxoguanine DNA glycosylase1-driven DNA repair-A paradoxical role in lung aging
Keywords: 8-oxoG; 7,8-dihydro-8-oxoguanine; 8-oxodG; 7,8-dihydro-8-oxo-2â²-deoxyguanosine; BER; base excision repair; DNA dsbs; double strand breaks; DNA ssbs; single strand breaks; GEF; guanine nucleotide exchange factor; GOrilla; Gene Ontology enrichment analysi
Differentiating the pre-hydrolysis states of wild-type and A59G mutant HRas: An insight through MD simulations
Keywords: RAS; RAt Sarcoma; GTP; Guanosine Tri-Phosphate; GNP; GTP Analogue GppNHp; HRas; Harvey Rat sarcoma; MD; Molecular Dynamics; CMD; Classical Molecular Dynamics; Sw I; Switch-1; Sw II; Switch-2; P-loop; Phosphate-binding loop; A59GRas; Mutant HRas; Pre-hydro
Differential Effects of HRAS Mutation on LTP-Like Activity Induced by Different Protocols of Repetitive Transcranial Magnetic Stimulation
Keywords: Plasticity; TMS; HRAS; Costello; iTBS; PAS;
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations
Keywords: Porocarcinoma; Poroma; HRAS; TP53; Epidermal growth factor receptor; RB1
ReviewSearching for the Chokehold of NRAS Mutant Melanoma
Keywords: ERK; extracellular signal-regulated kinase; GEF; guanine nucleotide exchange factor; HRAS; Harvey-rat-sarcoma homolog; KRAS; Kirsten-rat-sarcoma homolog; MAPK; mitogen-activated protein kinase; NRAS; neuroblastoma rat-sarcoma homolog; RAL; retinaldehyde;
Mutation spectra of RAS gene family in colorectal cancer
Keywords: Colorectal cancer; KRAS; NRAS; HRAS; Survival;
T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA
Keywords: NIH/3T3; HRAS; Tansformed; GhrasT-NIH/3T3; In vitro/in vivo tumorigenic progression; Metastasis; Punctuated evolution; Chromoplexy; Chromothripsis; Doubling time method;
G4 DNA in ras genes and its potential in cancer therapy
Keywords: KRAS; HRAS; NRAS; G-quadruplex; Antigene strategies; Promoter; 5â²-UTR;
Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum
Keywords: HRAS; KRAS; BRAF; Trichoblastoma; Syringocystadenoma papilliferum
Congenital muscular dystrophy phenotype with neuromuscular spindles excess in a 5-year-old girl caused by HRAS mutation
Keywords: CMD; Ullrich congenital muscular dystrophy; HRAS; Excess of neuromuscular spindles;
CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma
Keywords: Vulva; Squamous cell carcinoma; Somatic mutation; CDKN2A; HRAS; Survival;
Scribble controls NGF-mediated neurite outgrowth in PC12 cells
Keywords: Scribble; Cell polarity; Neurite outgrowth; MAPK pathway; HRas; Erk1/2;
Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP)
Keywords: AP-1; activator protein-1; ASC; apoptosis-associated speck-like protein containing a CARD domain; ASK; apoptosis signal-regulating kinase; ATM; Ataxia Telangiectasia Mutated; ATR; ATM and Rad 3-related; BRCA1; breast cancer 1; CARD; caspase activation and
ZespóÅ Costello jako przykÅad rzadkich zaburzeÅ funkcji szlaku sygnalnego Ras-MAPK: obraz kliniczny i diagnostyka molekularna choroby
Keywords: zespóÅ Costello; HRAS; szlak Ras-MAPK; brodawczaki; kardiomiopatia przerostowa; niepeÅnosprawnoÅÄ intelektualna; nowotwory; Costello syndrome; HRAS; Ras-MAPK pathway; papillomata; cardiomyopathy; mental retardation; malignancy;
Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation
Keywords: CRC; colorectal cancer; APC; Adenomatous Polyposis Coli; GEF; guanine nucleotide exchange factor; GAP; GTPase activating protein; NL; non-linear; EBI; European Bioinformatics Institute; XCorr; cross-correlation number; DelCn; Delta correlation number; BCA
Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
Keywords: Noninvasive urothelial carcinoma; First presentation; Recurrence; Progression; CCND3; HRAS; E2F1; Survivin; VEGFR2; VEGF